Do platelet function testing and genotyping improve outcome in patients treated with antithrombotic agents?: platelet function testing and genotyping improve outcome in patients treated with antithrombotic agents.
Publication
, Journal Article
Gurbel, PA; Tantry, US
Published in: Circulation
March 13, 2012
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Circulation
DOI
EISSN
1524-4539
Publication Date
March 13, 2012
Volume
125
Issue
10
Start / End Page
1276 / 1287
Location
United States
Related Subject Headings
- Ticlopidine
- Thrombosis
- Risk Factors
- Receptors, Purinergic P2Y12
- Purinergic P2Y Receptor Antagonists
- Platelet Function Tests
- Platelet Aggregation Inhibitors
- Pharmacogenetics
- Humans
- Genotype
Citation
APA
Chicago
ICMJE
MLA
NLM
Gurbel, P. A., & Tantry, U. S. (2012). Do platelet function testing and genotyping improve outcome in patients treated with antithrombotic agents?: platelet function testing and genotyping improve outcome in patients treated with antithrombotic agents. Circulation, 125(10), 1276–1287. https://doi.org/10.1161/CIRCULATIONAHA.111.031195
Gurbel, Paul A., and Udaya S. Tantry. “Do platelet function testing and genotyping improve outcome in patients treated with antithrombotic agents?: platelet function testing and genotyping improve outcome in patients treated with antithrombotic agents.” Circulation 125, no. 10 (March 13, 2012): 1276–87. https://doi.org/10.1161/CIRCULATIONAHA.111.031195.
Gurbel PA, Tantry US. Do platelet function testing and genotyping improve outcome in patients treated with antithrombotic agents?: platelet function testing and genotyping improve outcome in patients treated with antithrombotic agents. Circulation. 2012 Mar 13;125(10):1276–87.
Gurbel, Paul A., and Udaya S. Tantry. “Do platelet function testing and genotyping improve outcome in patients treated with antithrombotic agents?: platelet function testing and genotyping improve outcome in patients treated with antithrombotic agents.” Circulation, vol. 125, no. 10, Mar. 2012, pp. 1276–87. Pubmed, doi:10.1161/CIRCULATIONAHA.111.031195.
Gurbel PA, Tantry US. Do platelet function testing and genotyping improve outcome in patients treated with antithrombotic agents?: platelet function testing and genotyping improve outcome in patients treated with antithrombotic agents. Circulation. 2012 Mar 13;125(10):1276–1287.
Published In
Circulation
DOI
EISSN
1524-4539
Publication Date
March 13, 2012
Volume
125
Issue
10
Start / End Page
1276 / 1287
Location
United States
Related Subject Headings
- Ticlopidine
- Thrombosis
- Risk Factors
- Receptors, Purinergic P2Y12
- Purinergic P2Y Receptor Antagonists
- Platelet Function Tests
- Platelet Aggregation Inhibitors
- Pharmacogenetics
- Humans
- Genotype